Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
1.530
-0.060 (-3.77%)
At close: Dec 10, 2025, 4:00 PM EST
1.450
-0.080 (-5.23%)
After-hours: Dec 10, 2025, 7:59 PM EST
Psyence Biomedical Employees
Psyence Biomedical had 12 employees as of March 31, 2025.
Employees
12
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$328,466
Market Cap
2.86M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PBM News
- 1 day ago - Psyence BioMed CEO Letter Highlights Clinical Progress, Ethical Sourcing of Ibogaine, Strong Cash Position and Expanding Leadership in Longevity Science - GlobeNewsWire
- 15 days ago - Psyence BioMed Announces Groundbreaking Psilocybin Longevity Research Program - GlobeNewsWire
- 20 days ago - Psyence BioMed Reaches Major Breakthrough in Pharmaceutical-Grade Ibogaine Supply for Worldwide Clinical and Therapeutic Markets - GlobeNewsWire
- 4 weeks ago - Psyence BioMed Establishes Ibogaine Operations in Africa Through Strategic Investment in PsyLabs - GlobeNewsWire
- 4 weeks ago - Psyence BioMed Doses Multiple Patients and Expands Clinical Sites in Phase IIb Study for Adjustment Disorder in Palliative Care - GlobeNewsWire
- 5 weeks ago - Psyence BioMed Strengthens Strategic Partnership with PsyLabs Through USD $3,500,000 Follow-On Investment - GlobeNewsWire
- 3 months ago - Psyence BioMed to Present at the H.C. Wainwright 27th Annual Global Investment Conference September 8-10, 2025 - GlobeNewsWire
- 4 months ago - Psyence BioMed's Strategic Collaboration with PsyLabs Yields Breakthrough in High-Purity Ibogaine Production - GlobeNewsWire